Table 1.
Location | ||||
---|---|---|---|---|
Characteristics | Total (n = 834) | Wuhan (n = 374) | Outside Wuhan (n = 460) | P |
Basic characteristics | ||||
Age (years) | 0.422 | |||
< 46 | 291 (34.9) | 125 (33.4) | 166 (36.1) | |
≥ 46 | 543 (65.1) | 249 (66.6) | 294 (63.9) | |
Educational level | 0.001 | |||
Junior school or lower | 96 (11.5) | 33 (8.8) | 63 (13.7) | |
High school | 425 (51.0) | 176 (47.1) | 249 (54.1) | |
College or higher | 313 (37.5) | 165 (44.1) | 148 (32.2) | |
Marital status | 0.131 | |||
Married | 717 (86.0) | 314 (84.0) | 403 (87.6) | |
Single/divorced/windowed | 117 (14.0) | 60 (16.0) | 57 (12.4) | |
Menstrual status | < 0.001 | |||
Menstruating | 281 (33.7) | 113 (30.2) | 168 (36.5) | |
Perimenopausal | 156 (18.7) | 55 (14.7) | 101 (22.0) | |
Postmenopause | 397 (47.6) | 206 (55.1) | 191 (41.5) | |
Comorbidity | 0.196 | |||
No | 431 (51.7) | 184 (49.2) | 247 (53.7) | |
Yes | 403 (48.3) | 190 (50.8) | 213 (46.3) | |
Living alone | 0.549 | |||
No | 785 (94.6) | 350 (93.6) | 435 (94.6) | |
Yes | 49 (5.9) | 24 (6.4) | 25 (5.4) | |
Stage of breast cancer | 0.724 | |||
Early or middle stage | 757 (90.8) | 338 (90.4) | 419 (91.9) | |
Late stage | 77 (9.2) | 36 (9.6) | 41 (8.9) | |
Deterioration of breast cancer | 0.013 | |||
No | 359 (43.0) | 145 (38.8) | 214 (46.5) | |
Not sure | 399 (47.8) | 200 (53.5) | 199 (43.3) | |
Yes | 76 (9.1) | 29 (7.8) | 47 (10.2) | |
Affected treatment plan | 0.369 | |||
No | 324 (38.8) | 139 (37.2) | 185 (40.2) | |
Yes | 510 (61.2) | 235 (62.8) | 275 (59.8) | |
Duration of treatment interruptiona | 0.019 | |||
2–4 weeks | 89 (17.5) | 40 (17.0) | 49 (17.8) | |
4–6 weeks | 98 (19.2) | 59 (25.1) | 39 (14.2) | |
6–8 weeks | 101 (19.8) | 48 (20.4) | 53 (19.3) | |
≥ 8 weeks | 145 (28.4) | 58 (24.7) | 87 (31.6) | |
Not sure | 77 (15.1) | 30 (12.8) | 47 (17.1) | |
Reason for treatment interruptiona | 0.004 | |||
Traffic control | 292 (57.3) | 117 (49.8) | 175 (63.6) | |
No hospital beds or appointment hours | 66 (12.9) | 42 (17.9) | 24 (8.7) | |
Fear of infection | 134 (26.3) | 67 (28.5) | 67 (24.4) | |
Personal other reasons | 18 (3.5) | 9 (3.8) | 9 (3.3) | |
Discontinued anticancer therapya | 0.105 | |||
Delayed surgery | 44 (8.6) | 17 (7.2) | 27 (9.8) | |
Chemotherapy after surgery | 101 (19.8) | 43 (18.3) | 58 (21.1) | |
Endocrine therapy after surgery | 77 (15.1) | 46 (19.6) | 31 (11.3) | |
Targeted therapy after surgery | 65 (12.7) | 30 (12.8) | 35 (12.7) | |
Radiotherapy after surgery | 15 (2.9) | 9 (3.8) | 6 (2.2) | |
Reexamination | 208 (40.8) | 90 (38.3) | 118 (42.9) | |
Psychological distress | ||||
Depression | 0.371 | |||
No | 654 (78.4) | 288 (77.0) | 366 (79.6) | |
Yes | 180 (21.6) | 86 (23.0) | 94 (20.6) | |
Anxiety | 0.117 | |||
No | 705 (84.5) | 308 (82.4) | 397 (86.3) | |
Yes | 129 (15.5) | 66 (17.6) | 63 (13.7) | |
Insomnia | 0.124 | |||
No | 711 (85.3) | 311 (83.2) | 400 (87.0) | |
Yes | 123 (14.7) | 63 (16.8) | 60 (13.0) |
Data are presented as number (%)
Percentages are weighted to account for the sample size, n = 834
aPercentages are weighted to the size of the group of patients whose treatment plan was affected, n = 510